Author
Listed:
- Haileyesus Getahun
- Wanitchaya Kittikraisak
- Charles M Heilig
- Elizabeth L Corbett
- Helen Ayles
- Kevin P Cain
- Alison D Grant
- Gavin J Churchyard
- Michael Kimerling
- Sarita Shah
- Stephen D Lawn
- Robin Wood
- Gary Maartens
- Reuben Granich
- Anand A Date
- Jay K Varma
Abstract
Haileyesus Getahun and colleagues report the development of a simple, standardized tuberculosis (TB) screening rule for resource-constrained settings, to identify people living with HIV who need further investigation for TB disease.Background: The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded. However, the difficulty of reliably excluding TB disease has severely limited TB screening and IPT uptake in resource-limited settings. We conducted an individual participant data meta-analysis of primary studies, aiming to identify a sensitive TB screening rule. Methods and Findings: We identified 12 studies that had systematically collected sputum specimens regardless of signs or symptoms, at least one mycobacterial culture, clinical symptoms, and HIV and TB disease status. Bivariate random-effects meta-analysis and the hierarchical summary relative operating characteristic curves were used to evaluate the screening performance of all combinations of variables of interest. TB disease was diagnosed in 557 (5.8%) of 9,626 people living with HIV. The primary analysis included 8,148 people living with HIV who could be evaluated on five symptoms from nine of the 12 studies. The median age was 34 years. The best performing rule was the presence of any one of: current cough (any duration), fever, night sweats, or weight loss. The overall sensitivity of this rule was 78.9% (95% confidence interval [CI] 58.3%–90.9%) and specificity was 49.6% (95% CI 29.2%–70.1%). Its sensitivity increased to 90.1% (95% CI 76.3%–96.2%) among participants selected from clinical settings and to 88.0% (95% CI 76.1%–94.4%) among those who were not previously screened for TB. Negative predictive value was 97.7% (95% CI 97.4%–98.0%) and 90.0% (95% CI 88.6%–91.3%) at 5% and 20% prevalence of TB among people living with HIV, respectively. Abnormal chest radiographic findings increased the sensitivity of the rule by 11.7% (90.6% versus 78.9%) with a reduction of specificity by 10.7% (49.6% versus 38.9%). Conclusions: Absence of all of current cough, fever, night sweats, and weight loss can identify a subset of people living with HIV who have a very low probability of having TB disease. A simplified screening rule using any one of these symptoms can be used in resource-constrained settings to identify people living with HIV in need of further diagnostic assessment for TB. Use of this algorithm should result in earlier TB diagnosis and treatment, and should allow for substantial scale-up of IPT. : Please see later in the article for the Editors' Summary Background: In 2009, 1.7 million people died from tuberculosis (TB)—equating to 4,700 deaths a day—including 380,000 people living with HIV. TB remains the most common cause of death in people living with HIV and compared to people without HIV, people living with HIV are more than 20 times more likely to develop TB. Furthermore, TB infection may occur at any stage of HIV disease and is often the initial presentation of underlying HIV infection. Without antiretroviral treatment, up to 50% of people living with HIV who are diagnosed with TB die during the 6–8 months of TB treatment. Why Was This Study Done?: There is currently no internationally accepted evidence-based tool to screen for TB in people living with HIV—a serious gap given that the presenting signs and symptoms of TB in people living with HIV are different from those in people without HIV. Therefore, the researchers aimed to develop a simple, standardized TB screening rule for resource-constrained settings, on the basis of the best available evidence that would adequately distinguish between people living with HIV who are very unlikely to have TB from those who require further investigation for TB disease. What Did the Researchers Do and Find?: The researchers selected 12 studies that met their strict criteria, then asked the authors of these studies for primary data so that they could map individual-level data to identify five symptoms common to most studies. Using a statistical model, the researchers devised 23 screening rules derived from these five symptoms and used meta-analysis methods (bivariate random-effects meta-analysis) and the association of study-level and individual-level correlates (hierarchical summary relative operating characteristic curves) to evaluate the sensitivity and specificity of each tool used in each individual study. What Do These Findings Mean?: The results of this study suggest that in resource-constrained settings, the absence of current cough, fever, night sweats, and weight loss (all inclusive) can identify those people living with HIV who have a low probability of having TB disease. Furthermore, any one of these symptoms can be used in resource-constrained settings to identify people living with HIV who are in need of further diagnostic assessment for TB. Additional Information: Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000391.
Suggested Citation
Haileyesus Getahun & Wanitchaya Kittikraisak & Charles M Heilig & Elizabeth L Corbett & Helen Ayles & Kevin P Cain & Alison D Grant & Gavin J Churchyard & Michael Kimerling & Sarita Shah & Stephen D L, 2011.
"Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies,"
PLOS Medicine, Public Library of Science, vol. 8(1), pages 1-14, January.
Handle:
RePEc:plo:pmed00:1000391
DOI: 10.1371/journal.pmed.1000391
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Surbhi Modi & Joseph S Cavanaugh & Ray W Shiraishi & Heather L Alexander & Kimberly D McCarthy & Barbara Burmen & Hellen Muttai & Chad M Heilig & Allyn K Nakashima & Kevin P Cain, 2016.
"Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya,"
PLOS ONE, Public Library of Science, vol. 11(12), pages 1-14, December.
- Zhezhe Cui & Fei Huang & Dabin Liang & Yan Huang & Huifang Qin & Jing Ye & Liwen Huang & Chongxing Zhou & Minying Huang & Xiaoyan Liang & Fengxue Long & Yanlin Zhao & Mei Lin, 2022.
"Tuberculosis among Ambulatory People Living with HIV in Guangxi Province, China: A Longitudinal Study,"
IJERPH, MDPI, vol. 19(19), pages 1-9, September.
- Jennifer A Gilbert & Sheela V Shenoi & Anthony P Moll & Gerald H Friedland & A David Paltiel & Alison P Galvani, 2016.
"Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa,"
PLOS ONE, Public Library of Science, vol. 11(12), pages 1-19, December.
- Franz Ratzinger & Harald Bruckschwaiger & Martin Wischenbart & Bernhard Parschalk & Delmiro Fernandez-Reyes & Heimo Lagler & Alexandra Indra & Wolfgang Graninger & Stefan Winkler & Sanjeev Krishna & M, 2012.
"Rapid Diagnostic Algorithms as a Screening Tool for Tuberculosis: An Assessor Blinded Cross-Sectional Study,"
PLOS ONE, Public Library of Science, vol. 7(11), pages 1-6, November.
- Mary D Ari & John Iskander & John Araujo & Christine Casey & John Kools & Bin Chen & Robert Swain & Miriam Kelly & Tanja Popovic, 2020.
"A science impact framework to measure impact beyond journal metrics,"
PLOS ONE, Public Library of Science, vol. 15(12), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:1000391. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.